21174 ⎘
Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA; Virus avirulent or attenuated
Recombinant flaviviral constructs and uses thereof
#902Influenza viruses with mutant PB2 gene segment as live attenuated vaccines
#903Immediate protection against pathogens via MVA
#904Recombinant virus with diminished latency and methods of using same
#905Vaccine against beta-herpesvirus infection and use thereof
#906Live attenuated parvovirus
#907BVDV vaccine
#908Multi plasmid system for the production of influenza virus
#909Flavivirus vaccines
#910Influenza hemagglutinin and neuraminidase variants
#911Recombinant modified vaccinia virus Ankara influenza vaccine
#912Compositions and methods for rapid immunization against dengue virus
#913Chimeric infectious DNA clones, chimeric porcine circoviruses and uses thereof
#914Modified live-attenuated vaccines (MLV) created by DNA shuffling against porcine reproductive and respiratory syndrome virus (PRRSV)
#915Recombinant HCMV and RHCMV vectors and uses thereof
#916Marker vaccine for classical swine fever
#917Recombinant non-pathogenic marek's disease virus constructs encoding infectious laryngotracheitis virus and newcastle disease virus antigens
#918Methods for the induction of ebola virus-specific immune responses comprising administering a replication-defective chimpanzee adenovirus vector expressing the ebola virus glycoprotein
#919Development of dengue virus vaccine components
#920Vaccines comprising cholesterol and CpG as sole adjuvant-carrier molecules
#921BUNYAVIRUS VACCINE
#922Piscine reovirus immunogenic compositions
#923Attenuated human parainfluenza virus, methods and uses thereof
#924Infectious DNA vaccines against chikungunya virus
#925Autologous biological cancer vaccine
#926Avirulent oncolytic herpes simplex virus strains engineered to counter the innate host response
#927Bovine herpes virus vaccine with multiple mutations
#928Agent for use in the topical or local treatment of cervical dysplasias
#929Genetically engineered swine influenza virus and uses thereof
#930HERPES SIMPLEX VIRUS COMBINED SUBUNIT VACCINES AND METHODS OF USE THEREOF
#931Synergistic attenuation of vesicular stomatitis virus, vectors thereof and immunogenic compositions thereof
#932Pseudoinfectious flavivirus and uses thereof
#933Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#934Tuberculosis vaccine
#935Modified influenza virus for monitoring and improving vaccine efficiency
#936ADJUVANT DILUENTS FOR LIVE VACCINES FOR PIG DISEASES
#937Dengue tetravalent vaccine containing a common 30 nucleotide deletion in the 3′-UTR of dengue types 1, 2, 3, and 4, or antigenic chimeric dengue viruses 1, 2, 3, and 4
#938Disrupted adenovirus-based vaccine against drugs of abuse
#939Recombinant attenuated parvovirus
#940MODIFIED VACCINIA ANKARA VIRUS VARIANT
#941Live vaccine for avian diseases
#942Development of a marker foot and mouth disease virus vaccine candidate that is attenuated in the natural host
#943Recombinant RSV Virus Expression Systems And Vaccines
#944Immunological Compositions for HIV
#945Reassortant influenza B viruses
#946HENDRA VIRUS RECOMBINANT COMPOSITIONS AND USES THEREOF
#947CYTOMEGALOVIRUS-BASED IMMUNOGENIC PREPARATIONS
#948Pneumovirus compositions and methods for using the same
#949Multi plasmid system for the production of influenza virus
#950FUNCTIONAL MUTATION IN RESPIRATORY SYNCYTIAL VIRUS
#951Modified Vaccinia Ankara virus variant and cultivation method
#952USE OF NEWCASTLE DISEASE VIRUS-BASED VECTOR FOR INDUCING AN IMMUNE RESPONSE IN MAMMALS
#953Rapid and prolonged immunologic-therapeutic
#954Microorganisms for therapy
#955Reverse genetics systems
#956ATTENUATED DENGUE VIRUS VACCINE CONTAINING ADAPTIVE MUTATION FROM MRC-5 CELLS
#957ATTENUATED INFLUENZA VIRUSES AND VACCINES
#958Vaccines containing canine parvovirus genetic variants
#959Methods and compositions for eliciting an immune response against hepatitis B virus
#960Herpes simplex virus vaccines
#961Compositions And Methods Involving Respiratory Syncytial Virus Subgroup B Strain 9320
#962Methods and compositions for the treatment of influenza
#963Attenuated negative strand viruses with altered interferon antagonist activity for use as vaccines and pharmaceuticals
#964Human Ebola Virus Species and Compositions and Methods Thereof
#965Swine influenza hemagglutinin variants
#966Influenza viruses and uses thereof
#967Live attenuated rotavirus vaccine for oral administration
#968Equine rhinitis vaccine
#969Polynucleotide Fragments of an Infectious Human Endogenous Retrovirus
#970INACTIVATED POULTRY VACCINE
#971Methods for purification of viruses
#972Chimeric HIV fusion proteins as vaccines
#973European PRRSV strain
#974Insertion of foreign genes in rubella virus and their stable expression in a live, attenuated viral vaccine
#975Vaccines against japanese encephalitis virus and west nile virus
#976Infectious bovine viral diarrhea virus
#977Chimeric poly peptides and the therapeutic use thereof against a flaviviridae infection
#978Multi plasmids system for the production of influenza virus
#979gM-negative EHV-mutants without heterologous elements
#980Attenuated pestiviruses
#981Attenuated live vaccine for prevention of porcine reproductive and respiratory syndrome
#982MODIFIED VACCINIA VIRUS ANKARA FOR THE VACCNATION OF NEONATES
#983Methods for preparing vesicles and formulations produced therefrom
#984IMMUNIZATION TO REDUCE NEUROTOXICITY DURING TREATMENT WITH CYTOLYTIC VIRUSES
#985Method of preparing live viral vaccines by genetic engineering of viral genome
#986Porcine circovirus type 2 (PCV2), immunogenic composition containing the same, test kit, and application thereof
#987BOVINE HERPESVIRUS VACCINE
#988Nucleic acids encoding modified Ebola virus glycoproteins with diminished cytotoxicity while retaining native antigenic structures
#989Live attenuated influenza virus vaccines comprising microRNA response elements
#990COMPOSITIONS AND METHODS FOR VACCINATING CATTLE
#991PRRSV GP5 BASED COMPOSITIONS AND METHODS
#992Virus vaccination and treatment methods with OX40 agonist compositions
#993Induction of an immune response against dengue virus using the prime-boost approach
#994Influenza hemagglutinin and neuraminidase variants
#995Alphavirus Replicon Particles Expressing TRP2
#996Replication-Defective Flavivirus Vaccine Vectors Against Respiratory Syncytial Virus
#997NEUTRALIZING MOLECULES TO INFLUENZA VIRUSES
#998LIVE ORGANISM PRODUCT
#999Chimeric Virus Vaccines
#1000SUPRALINGUAL VACCINES AND APPLICATORS
#1001Human rotavirus vaccine strains and diagnostics
#1002HSV-1 and HSV-2 vaccines and methods of use thereof
#1003Recombinant attenuated dengue viruses comprising mutations in NS5 and the 3′ untranslated region
#1004Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
#1005Subgenomic replicons of the flavivirus dengue
#1006Composition useful as rotavirus vaccine and a method therefor
#1007Attenuation of encephalitogenic alphavirus and uses thereof
#1008COMPOSITIONS AND METHODS FOR THE TREATMENT OF HEPATITIS C
#1009Dengue serotype 2 attenuated strain
#1010Dengue serotype 1 attenuated strain
#1011Method for prophylaxis of influenza using vaccine for intranasal administration
#1012Antigenic chimeric tick-borne encephalitis virus/dengue virus type 4 recombinant viruses
#1013Immunogenic composition and use thereof
#1014MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
#1015Methods for preparing and delivering adjuvant compositions
#1016PRODUCTION OF ATTENUATED NEGATIVE STRANDED RNA VIRUS VACCINES FROM CLONED NUCLEOTIDE SEQUENCES
#1017Tetravalent influenza vaccine and use thereof
#1018RECOMBINANT PARAINFLUENZA VIRUS VACCINE COMPRISING HETEROLOGOUS ANTIGENS DERIVED FROM RESPIRATORY SYNCYTIAL VIRUS
#1019Porcine circovirus type 2B isolate and uses thereof
#1020Microparticulated vaccines for the oral or nasal vaccination and boostering of animals including fish
#1021COMPOSITIONS AND METHODS FOR VACCINE AND VIRUS PRODUCTION
#1022Induction of an immune response against dengue virus using the prime-boost approach
#1023Poultry viral materials and methods related thereto
#1024Circovirus sequences associated with piglet weight loss disease (PWD)
#1025INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#1026INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#1027Bovine herpes virus-1 compositions, vaccines and methods
#1028HCV vaccines and methods for using the same
#1029Preservation of bioactive materials by freeze dried foam
#1030Multi plasmid system for the production of influenza virus
#1031Cellular permissivity factor for viruses and uses thereof
#1032N-linked glycosylation alteration in E1 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#1033Avirulent, immunogenic flavivirus chimeras
#1034MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
#1035MONOPARAMUNITY INDUCERS BASED ON ATTENUATED RABBIT MYXOMAVIRUSES
#1036Influenza hemagglutinin and neuraminidase variants
#1037Circovirus sequences associated with piglet weight loss disease (PWD)
#1038Infectious genotype 1a, 1b, 2a, 2b, 3a, 5a, 6a and 7a hepatitis C virus lacking the hypervariable region 1 (HVR1)
#1039RECOMBINANT RACCOON POX VIRUS VACCINE AGAINST HIGHLY PATHOGENIC AVIAN INFLUENZA
#1040Flavivirus host-range mutations and uses thereof
#1041Enterovirus Vaccines for Preventing or Treating Type 1 Diabetes (I)
#1042Flaviviruses expressing the prM, E, and NS1 proteins of other flaviviruses and uses thereof
#1043Vaccine
#1044Infectious bronchitis vaccines derived from IB-QX-like vaccine strains
#1045Recombinant influenza vectors with tandem transcription units
#1046Microorganisms for therapy
#1047Modified vaccinia virus strains for use in diagnostic and therapeutic methods
#1048Equine disease model for herpesvirus neurologic disease and uses thereof
#1049RECOMBINANT KOI HERPESVIRUS (KHV) OR CYPRINID HERPESVIRUS 3 (CYHV-3) AND A VACCINE FOR THE PREVENTION OF A DISEASE CAUSED BY KHV/CYHV-3 IN CYPRINUS CARPIO CARPIO OR CYPRINUS CARPIO KOI
#1050Live attenuated chimeric porcine circovirus vaccine
#1051T-cell vaccination with viral vectors via mechanical epidermal disruption
#1052IMMUNIZATION OF AVIANS BY MUCOSAL ADMINISTRATION OF NON-REPLICATING VECTORED VACCINES
#1053Chimeric HIV Antigens
#1054Herpes simplex virus combined subunit vaccines and methods of use thereof
#1055RABIES VACCINE
#1056Method for generation of RNA virus
#1057DNA transfection system for the generation of negative strand RNA virus
#1058Vaccines comprising mutant attenuated influenza viruses
#1059Virulent oncolytic herpes simplex virus strains engineered to counter the innate host response
#1060MUTANT PESTIVIRUS WITH MUTATIONS IN CORE GENE AND NS3 REGION
#1061Method for production of pH stable enveloped viruses
#1062Modified Vaccinia Ankara virus variant and cultivation method
#1063Live, attenuated respiratory syncytial virus
#1064Influenza hemagglutinin and neuraminidase variants
#1065Dengue chimeric viruses
#1066Live attenuated virus vaccines for La Crosse virus and other Bunyaviridae
#1067Tissue targeted antigenic activation of the immune response to treat cancers
#1068Anti-HIV vaccine constructed based on amino acid mutations in attenuated live EIAV vaccine
#1069Recombinant Varicella-Zoster Virus
#1070RECOMBINANT HUMAN PARAINFLUENZA TYPE 1 VIRUSES (HPIV1s) CONTAINING MUTATIONS IN OR DELETION OF THE C PROTEIN ARE ATTENUATED IN AFRICAN GREEN MONKEYS AND IN CILIATED HUMAN AIRWAY EPITHELIAL CELLS AND ARE POTENTIAL VACCINE CANDIDATES FOR HPIV1
#1071PORCINE CIRCOVIRUS TYPE 2 AND USE THEREOF
#1072Influenza hemagglutinin and neuraminidase variants
#1073Modified virus variant
#1074Modified Vaccinia Ankara virus variant
#1075HSV-1 and HSV-2 vaccines and methods of use thereof
#1076Recombinant live attenuated foot-and-mouth disease (FMD) vaccine containing mutations in the L protein coding region
#1077Immediate protection against pathogens via MVA
#1078Viral strains derived from the vaccinia virus Lister VACV-107 and uses thereof
#1079Attenuated live vaccines
#1080Vaccines for inclusion body hepatitis
#1081Rabies virus-based recombinant immunocontraceptive compositions and methods of use
#1082Modified vaccinia virus ankara for the vaccination of neonates
#1083Avian influenza virus live attenuated vaccine and uses thereof
#1084Recovery of recombinant human parainfluenza virus type 2 (HYPIV2) from cDNA and use of recombinant HPIV2 in immunogenic compositions and as vectors to elicit immune responses against PIV and other human pathogens
#1085Use of a modified poxvirus for the rapid induction of immunity against a poxvirus or other infectious agents
#1086Replication-defective flavivirus vaccines and vaccine vectors
#1087Modified Vaccinia Virus Ankara for the vaccination of neonates
#1088Circovirus sequences associated with piglet weight loss disease (PWD)
#1089METHODS FOR GENERATING AN IMMUNE RESPONSE USING DNA AND A VIRAL VECTOR
#1090VACCINE DIRECTED AGAINST ADENOVIRUS SEROTYPE 14
#1091Recombinant Rift Valley fever (RVF) viruses and methods of use
#1092Infectious bursal disease virus antigenic isolates and vaccines
#1093Swine influenza hemagglutinin variants
#1094Vaccine Against Highly Pathogenic Porcine Reproductive and Respiratory Syndrome (HP PRRS)
#1095Attenuated pestivirus
#1096Vaccine against varicella zoster virus
#1097Modified influenza virus for monitoring and improving vaccine efficiency
#1098Porcine reproductive and respiratory syndrome vaccine based on isolate JA-142
#1099POULTRY VIRAL MATERIALS AND METHODS RELATED THERETO
#1100Recombinant Rhinovirus Vectors
#1101Inactivated Live-Attenuated Bluetongue Virus Vaccine
#1102Methods of stimulating an immune response against prostate specific antigen
#1103NOVEL VACCINE FOR DOG
#1104Influenza A virus with attenuating mutations in NS2 protein
#1105Rabies virus vector systems and compositions and methods thereof
#1106INFLUENZA HEMAGGLUTININ AND NEURAMINIDASE VARIANTS
#1107Viral vectors and their use in therapeutic methods
#1108Attenuated live triple G protein recombinant rabies virus vaccine for pre- and post-exposure prophylaxis of rabies
#1109Formulation for room temperature stabilization of a live attenuated bacterial vaccine
#1110Attenuated recombinant alphaviruses incapable of replicating in mosquitoes and uses thereof
#1111Compositions and methods using herpes simplex virus
#1112LEPORIPOXVIRUS-DERIVED VACCINE VECTORS
#1113Methods of vaccine administration, new feline caliciviruses, and treatments for immunizing animals against feline paraovirus and feline herpes virus
#1114Influenza hemagglutinin and neuraminidase variants
#1115VACCINE AGAINST VARICELLA ZOSTER VIRUS
#1116Recombinant RSV Virus Expression Systems And Vaccines
#1117Nucleic acid comprising chimeric gene derived from hepatitis C virus
#1118Infectious cDNA clone of North American porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#1119Cellular and viral inactivation
#1120-linked glycosylation alteration in E0 and E2 glycoprotein of classical swine fever virus and novel classical swine fever virus vaccine
#1121Circovirus sequences associated with piglet weight loss disease (PWD)
#1122Monoparamunity inducers based on attenuated rabbit myxoma viruses
#1123Viruses lacking epithelial cell receptor entry
#1124RECOMBINANT MODIFIED VACCINIA VIRUS ANKARA (MVA)-BASED VACCINE FOR THE AVIAN FLU
#1125Identification of protective antigenic determinants of porcine reproductive and respiratory syndrome virus and uses thereof
#1126Methods of preparing myxomavirus compositions
#1127HIV COMBINATION VACCINE AND PRIME BOOST
#1128Use of MVA to treat prostate cancer
#1129IMMUNOGENIC COMPOSITIONS CAPABLE OF ACTIVATING T-CELLS
#1130Identification of astrovirus VA1 associated with gastroenteritis in humans
#1131Influenza hemagglutinin and neuraminidase variants
#1132HUMAN PARAINFLUENZA VIRUSES HAVING SEPARATED P AND C GENES
#1133Influenza hemagglutinin and neuraminidase variants
#1134ATTENUATED MINUS-STRANDED RNA VIRUS
#1135Flaviviridae mutants comprising a deletion in the capsid protein for use as vaccines
#1136Method for producing vaccinal viral strain of a virus of the reoviridae family
#1137Modified influenza virus
#1138Influenza B viruses having alterations in the hemaglutinin polypeptide
#1139Monoparamunity inducers based on attenuated rabbit myxomaviruses
#1140CHIMERIC SLE/DENGUE TYPE 4 ANTIGENIC VIRUSES
#1141Compositions and methods for administration of vaccines against dengue virus
#1142Recombinant parainfluenza virus expression systems and vaccines comprising heterologous antigens derived from metapneumovirus
#1143Mutations in a toll-like receptor motif in the NS4B of classical swine fever virus strain brescia influences virulence in swine
#1144Compositions and vaccines against influenza A and influenza B infections
#1145Cytomegalovirus vaccines and methods of production
#1146Modified vaccinia ankara virus variant and cultivation method
#1147Medicaments and methods for treating mesothelioma
#1148Rabies Vaccine
#1149Nipah virus vaccines
#1150Chimeric flavivirus vaccines
#1151Cellular permissivity factor for viruses and uses thereof
#1152Vaccine for viruses that cause persistent or latent infections
#1153Mutant viruses and uses thereof
#1154Method of Immunization Against the 4 Dengue Serotypes
#1155Cattle reproductive disease vaccines
#1156Stabilizers for freeze-dried vaccines
#1157Avirulent, immunogenic flavivirus chimeras
#1158Stabilization of vaccines by lyophilization
#1159VIRUSES ENCODING MUTANT MEMBRANE PROTEIN
#1160Influenza A virus vaccines and inhibitors
#1161Method of Immunization Against the 4 Serotypes of Dengue Fever
#1162NOVEL METHODS AND INTERFERON DEFICIENT SUBSTRATES FOR THE PROPAGATION OF VIRUSES
#1163Subgenomic replicons of the flavivirus dengue
#1164Chikungunya virus infectious clones and uses therefor
#1165Methods of Treating and Preventing Neurological Symptoms Caused by Avian Reovirus and Novel Associated Characteristics
#1166Marek's disease virus vaccine compositions and methods of using thereof
#1167Immunogenic Compositions and Methods for Treating and Preventing Animal Infections
#1168Herpes simplex virus mutant ICP0
#1169Cellular and viral inactivation
#1170CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1171Chimeric poly peptides and the therapeutic use thereof against a Flaviviridae infection
#1172Malaria antigen screening method
#1173Infectious cDNA clone of the modified live virus vaccine strain of virus
#1174Method of Immunization Against the 4 Dengue Serotypes
#1175Circovirus sequences associated with piglet weight loss disease (PWD)
#1176CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1177Infectious cDNA of north american porcine reproductive and respiratory syndrome (PRRS) virus and uses thereof
#1178Dengue chimeric viruses
#1179CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1180PLASMODIUM AXENIC LIVER STAGES AS A NONINFECTIOUS WHOLE ORGANISM MALARIA VACCINE
#1181Attenuated viruses useful for vaccines
#1182CIRCOVIRUS SEQUENCE ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1183Recoding method that removes inhibitory sequences and improves HIV gene expression
#1184CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1185Functional Mutations In Respiratory Syncytial Virus
#1186Production of viral vaccine
#1187CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1188Circovirus sequences associated with piglet weight loss disease (PWD)
#1189CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1190CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1191CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1192CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1193Method for generation of RNA virus
#1194Process for preparing live smallpox vaccine
#1195Attenuated recombinant newcastle disease virus and vaccine containing the same
#1196Method of treating pregnant cows and/or heifers
#1197Dengue serotype 2 attenuated strain
#1198Method for production of pH stable enveloped viruses
#1199CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)
#1200CIRCOVIRUS SEQUENCES ASSOCIATED WITH PIGLET WEIGHT LOSS DISEASE (PWD)